Sector: Medical
Industry: Medical-Generic Drugs
3-Year Growth Rate: 9,659%
2015 Revenue: $144,427,000
2012 Revenue: $1,480,000
Stock Ticker: SUPN
Supernus Pharmaceuticals Inc. is a specialty pharmaceutical company focused on developing and commercializing products for the treatment of central nervous system diseases. It is developing several product candidates in neurology and psychiatry to address opportunities in epilepsy and attention deficit hyperactivity disorder. Supernus Pharmaceuticals Inc. is based in Rockville, Maryland.
